Advances for ferroptosis in treating myocardial ischemia reperfusion injury
- VernacularTitle:铁死亡用于心肌缺血再灌注损伤治疗的研究进展
- Author:
Mengran WANG
1
;
Xiaochen YOU
;
Xingli XU
;
Hongyan DAI
;
Jun GUAN
Author Information
- Keywords: ferroptosis; myocardial ischemia-reperfusion injury; antioxidant system; iron me-tabolism; lipid metabolism; inflammatory response
- From: Journal of Clinical Medicine in Practice 2024;28(9):123-128,133
- CountryChina
- Language:Chinese
- Abstract: Ferroptosis,a new form of programmed cell death marked by iron-dependent phospho-lipid peroxidation,is regulated by complex cellular metabolic pathways,including iron metabolism,lipid metabolism,and oxidation-reduction system,is associated with many organ injuries and degenera-tion,and has great potential in the treatment of ischemic diseases and lipid peroxide-related degenera-tive diseases.Myocardial ischemia reperfusion injury(MIRI)is the most common cause of death in patients with acute myocardial infarction after revascularization therapy.Recent studies have shown that ferroptosis is intimately related to the pathological process of MIRI.Ferroptosis is associated with MIRI through oxidative stress,iron metabolism,lipid metabolism,endoplasmic reticulum stress and inflammatory response.Intervention of ferroptosis during reperfusion can effectively improve cardiac function and reduce myocardial infarct size.In this paper,the research progress was explored between ferroptosis and MIRI,and the specific role of ferroptosis in MIRI was discussed.
